Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Chemapi Biological Technology Co., Ltd., also known as Hunan Kemir Biotechnology, is a high-tech enterprise based in Changsha, China, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Founded by a team of senior engineers with extensive experience in the chemical and pharmaceutical sectors, the company focuses on therapeutic areas such as oncology, antipsychotics, carbapenems, and steroids. Its primary commercial products include Temozolomide and its intermediates, as well as various carbapenem side chains like those for Meropenem and Biapenem. Chemapi operates R&D laboratories in Changsha and Xiangtan, supported by a large-scale production base in Yueyang, enabling efficient scale-up from gram-grade to ton-grade quantities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tau-chem Hunan Chemapi Biological Technology.